Ajax-Loading

Sino Biopharmaceutical Ltd - Capital Lease Obligations

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.

The item "Capital-Lease-Obligations" stands at 104.28 Million Hong Kong Dollars as of 06/30/2025, the lowest value since 12/31/2020.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -32.29 percent compared to the value the year prior.
The 1 year change in percent is -32.29.
The 3 year change in percent is -74.29.
The 5 year change in percent is 33.00.

The Serie's long term average value is 208.31 Million Hong Kong Dollars. It's latest available value, on 06/30/2025, is 49.94 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2019, to it's latest available value, on 06/30/2025, is +62.05%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -74.29%.

Capital Lease Obligations for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Capital Lease Obligations905,699,262,464.00
LogoJohnson & Johnson - Capital Lease Obligations486,508,953,600.00
LogoAbbVie Inc - Capital Lease Obligations399,570,305,024.00
LogoRoche Holding AG - Capital Lease Obligations317,433,206,677.55
LogoAstraZeneca PLC - Capital Lease Obligations280,205,508,085.11